These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10377651)
1. [Intravenous immunoglobulin therapy is more and more common. The increasing tempo can force a prioritization of patients, scientists are warning]. Orn P Lakartidningen; 1999 May; 96(18):2186-9. PubMed ID: 10377651 [No Abstract] [Full Text] [Related]
2. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?]. Vermeulen M Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702 [No Abstract] [Full Text] [Related]
10. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease. Czernik A Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786 [No Abstract] [Full Text] [Related]
11. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody. Bazin R; Lemieux R; Tremblay T Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577 [TBL] [Abstract][Full Text] [Related]
12. [Therapy with immunoglobulins]. Müller E; Zabel P Immun Infekt; 1990 Oct; 18(5):162-3. PubMed ID: 2265862 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin (IVIG)-mediated neutralisation of C5a: a direct mechanism of IVIG in the maintenance of a high Fc gammaRIIB to Fc gammaRIII expression ratio on macrophages. Konrad S; Baumann U; Schmidt RE; Gessner JE Br J Haematol; 2006 Aug; 134(3):345-7. PubMed ID: 16848778 [No Abstract] [Full Text] [Related]
14. [Use of high dose intravenous immunoglobulin in neurologic disease]. Korsak J; Zaleska B; Orłowska E; Kotowicz J Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039 [TBL] [Abstract][Full Text] [Related]
15. Plasma exchange and intravenous immunoglobulin infusion: antagonistic effects on mononuclear phagocyte functions with potential implications for therapy. Jungi TW; Nydegger UE Prog Clin Biol Res; 1990; 337():429-33. PubMed ID: 2191332 [No Abstract] [Full Text] [Related]
17. Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins. Nydegger UE; Sturzenegger T Ther Apher; 2001 Jun; 5(3):186-92. PubMed ID: 11467755 [TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction. Fuchs S; Feferman T; Zhu KY; Meidler R; Margalit R; Wang N; Laub O; Souroujon MC Ann N Y Acad Sci; 2007 Sep; 1110():550-8. PubMed ID: 17911471 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases. Rütter A; Luger TA Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544 [TBL] [Abstract][Full Text] [Related]
20. The science and arts of antibodies. Gupta S; Schwarz HP J Clin Immunol; 2014 Jul; 34 Suppl 1():S1-3. PubMed ID: 24760115 [No Abstract] [Full Text] [Related] [Next] [New Search]